Last reviewed · How we verify
Herpes Zoster vaccine GSK1437173A Modified — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Herpes Zoster vaccine GSK1437173A Modified (Herpes Zoster vaccine GSK1437173A Modified) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Herpes Zoster vaccine GSK1437173A Modified TARGET | Herpes Zoster vaccine GSK1437173A Modified | GlaxoSmithKline | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Herpes Zoster vaccine GSK1437173A Modified CI watch — RSS
- Herpes Zoster vaccine GSK1437173A Modified CI watch — Atom
- Herpes Zoster vaccine GSK1437173A Modified CI watch — JSON
- Herpes Zoster vaccine GSK1437173A Modified alone — RSS
Cite this brief
Drug Landscape (2026). Herpes Zoster vaccine GSK1437173A Modified — Competitive Intelligence Brief. https://druglandscape.com/ci/herpes-zoster-vaccine-gsk1437173a-modified. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab